Jeil Pharmaceutical Co Ltd (271980) — Net Asset Quality Index
Jeil Pharmaceutical Co Ltd (271980) has a Net Asset Quality Index of 48.1% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩526.12 Billion minus total liabilities of ₩272.85 Billion yields net assets of ₩253.26 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read total liabilities of Jeil Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Jeil Pharmaceutical Co Ltd Net Asset Quality Index Over Time (2017–2025)
This chart shows how Jeil Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the index stands at 48.1%, representing net assets of ₩253.26 Billion against total assets of ₩526.12 Billion KRW. For live market cap and overall valuation, see Jeil Pharmaceutical Co Ltd (271980) market capitalisation.
Annual Net Asset Quality Index for Jeil Pharmaceutical Co Ltd (2017–2025)
The table below presents the year-by-year Net Asset Quality Index for Jeil Pharmaceutical Co Ltd from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Jeil Pharmaceutical Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 49.2% | ₩251.03 Billion | ₩510.57 Billion | ₩259.55 Billion | ▲ +7.4 pp |
| 2024 | 41.7% | ₩219.32 Billion | ₩525.70 Billion | ₩306.38 Billion | ▲ +9.5 pp |
| 2023 | 32.2% | ₩157.03 Billion | ₩487.33 Billion | ₩330.29 Billion | ▼ -1.8 pp |
| 2022 | 34.1% | ₩155.60 Billion | ₩456.89 Billion | ₩301.29 Billion | ▼ -5.2 pp |
| 2021 | 39.2% | ₩167.35 Billion | ₩426.49 Billion | ₩259.14 Billion | ▼ -2.9 pp |
| 2020 | 42.1% | ₩172.48 Billion | ₩409.66 Billion | ₩237.18 Billion | ▼ -0.2 pp |
| 2019 | 42.3% | ₩170.04 Billion | ₩401.59 Billion | ₩231.54 Billion | ▼ -3.6 pp |
| 2018 | 45.9% | ₩184.93 Billion | ₩402.90 Billion | ₩217.97 Billion | ▲ +2.9 pp |
| 2017 | 43.0% | ₩177.99 Billion | ₩413.73 Billion | ₩235.74 Billion | — |